Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/26/2003EP1294750A2 Acid-modified arabinogalactan protein composition
03/26/2003EP1294747A2 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
03/26/2003EP1294746A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
03/26/2003EP1294745A2 Antimicrobial peptides and methods of use thereof
03/26/2003EP1294744A2 Peptides that stimulate cell survival and axon regeneration
03/26/2003EP1294743A2 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis
03/26/2003EP1294742A2 Urokinase inhibitors
03/26/2003EP1294741A2 Dipeptide inhibitors for the blood-clotting factor xa
03/26/2003EP1294740A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use
03/26/2003EP1294737A1 Antisense modulation of c/ebp beta expression
03/26/2003EP1294689A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
03/26/2003EP1294412A1 Method of using lectins for contraception and prophylaxis agains t diseases transmittable by sexual contact and condom containing lectins
03/26/2003EP1294409A2 Membrane-permeant peptide complexes for medical imaging
03/26/2003EP1294407A2 Dual recombinant gene therapy compositions and methods of use
03/26/2003EP1294406A2 Modulation of chromosome function by chromatin remodeling agents
03/26/2003EP1294404A2 Prodrug compounds with an oligopeptide having an isoleucine residue
03/26/2003EP1294403A2 Tripeptide prodrug compounds
03/26/2003EP1294401A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
03/26/2003EP1294395A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR
03/26/2003EP1294394A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR Xa INHIBITOR
03/26/2003EP1294393A2 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment and diagnosis of athersclerosis
03/26/2003EP1294392A2 Materials and methods relating for the treatment and diagnosis of pre-eclampsia
03/26/2003EP1294391A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
03/26/2003EP1294390A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
03/26/2003EP1294385A1 Method for the production of artificial oxygen carriers from covalently cross linking haemoglobin with improved functional properties of haemoglobin by cross-linking in the presence of chemically non-reacting effectors of the oxygen affinity of the haemoglobin
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP1294362A1 Novel process for preparing crystalline particles
03/26/2003EP1294361A2 Compositions and methods to improve the oral absorption of antimicrobial agents
03/26/2003EP1294356A2 Sustained release delivery systems for solutes
03/26/2003EP1150701A4 Homing pro-apoptotic conjugates and methods of using same
03/26/2003EP1064012A4 Enhancement of the pro-fertility action of a molecule involved in sperm-egg binding
03/26/2003EP1042339B1 Carbohydrates, useful in solid delivery systems
03/26/2003EP1032373B1 Drug delivery systems utilizing liquid crystal structures
03/26/2003EP0994898B1 Integrin binding peptide and use thereof
03/26/2003EP0956038B1 Morphogen peptide-induced regeneration of sense perceptory tissues
03/26/2003EP0950063B1 Multiple branch peptide constructions
03/26/2003EP0939809B1 Tie-2 receptor ligand (tie ligand-4) and its use
03/26/2003EP0900383B1 Peptides having specific affinity to pacap type 1 receptors
03/26/2003EP0885186B1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/26/2003EP0877599B1 Sustained delivery of leuprolide using an implantable system
03/26/2003EP0871653B1 Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds
03/26/2003EP0869969B1 PEPTIDE CONJUGATES, USE THEREOF AS A DRUG, AND COMPOSITIONS CONTAINING them
03/26/2003EP0833658B1 Inhibin compositions and methods of enhancing production performance
03/26/2003EP0831867B1 Collagen-based delivery matrix
03/26/2003EP0804229B1 Use of amlodipine, a salt thereof or felodipin in combination with an ace inhibitor in the manufacture of a medicament for the treatment of nonischemic congestive heart failure
03/26/2003EP0772436B1 Incorporation of biologically active molecules into bioactive glasses
03/26/2003EP0769962B1 Method of attenuating arterial stenosis
03/26/2003EP0759037B1 Antigen/antibody specificity exchanger
03/26/2003EP0625159B1 Ikaros: a regulatory gene involved in t-cell differentiation
03/26/2003EP0431135B1 Particle-mediated transformation of animal somatic cells
03/26/2003EP0431128B1 Vector coding for self-assembled, defective, non-self-propagating viral particles
03/26/2003EP0261224B2 Synthetic htlv-iii peptides, compositions and uses thereof
03/26/2003CN1406280A Progenitor cell preservation factors and related methods and products
03/26/2003CN1406278A Expression of recombinant mature lysostaphin
03/26/2003CN1406276A Sericin-containing material, Process for producing the same and method of using the same
03/26/2003CN1406245A Method of eliminating human serum albumin polymers
03/26/2003CN1406243A Memno peptides, a process for their preparation and their use
03/26/2003CN1406233A Medicine for viral diseases
03/26/2003CN1406226A Novel malonic acid derivatives, process for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
03/26/2003CN1406223A Protease inhibitor and their pharmaceutical uses
03/26/2003CN1406140A Nano capsule encapsulation system and method
03/26/2003CN1406137A Caspase activated prodrugs therapy
03/26/2003CN1406134A Drugs for ameliorating retinal function
03/26/2003CN1406133A New uses of insulin and pancreatin
03/26/2003CN1406132A Method for treating or inhibiting cellular injury or cell death
03/26/2003CN1406125A Method for transdermal or intradermal delivery of molecules
03/26/2003CN1406124A Nasally administrable cyclic peptide compositions
03/26/2003CN1405310A Method for producing medicine using silkworm expressed numan epidermal growth factor
03/26/2003CN1405309A Method for preparing medicine using silkworm expressed human beta interferon
03/26/2003CN1405308A Method for producing medicine using silkworm expressed human alpha2b interferon
03/26/2003CN1405301A Polypeptide-alcohol dehydrogenase III-51.37 and polynucleotide coding said polypeptide
03/26/2003CN1405184A Anti-small cell lung carcinoma polypeptide mixture
03/26/2003CN1405180A Chemotactic factor beta-8 short type
03/26/2003CN1405150A Protein modifier, preparation method and use thereof
03/26/2003CN1405127A Nitrogenous group conversion method
03/26/2003CN1404877A Blood-platelet specific mosaic immune globulin and its using method
03/26/2003CN1404876A Use of anti-CTLA anti-body
03/26/2003CN1404872A Method for producing antithrombotic medicine by using silk-worm
03/26/2003CN1404860A Chinese medicine multienzyme emulsifying method
03/26/2003CN1404833A 药物组合物 The pharmaceutical composition of
03/26/2003CN1103818C Process for producing phosphatidylserines having having polybasic unsaturated fatty acid and as side chain
03/26/2003CN1103815C Thrombin mutants
03/26/2003CN1103812C Human beta-2 integrin alpha subunit
03/26/2003CN1103782C Mono-pegylated MGDF polypeptide
03/26/2003CN1103781C Abundant extracellular product and methods for production and use of same
03/26/2003CN1103775C Vitronectin receptor antagonists, their preparation and use
03/26/2003CN1103606C Bi papcitide-based pharmaceutical compositions for imaging and treating thrombi
03/26/2003CN1103602C Process for preparing pharmaceutical formulation containing insulin analog
03/26/2003CN1103601C Release-controlled somatotropin composition and method for preparation thereof
03/26/2003CN1103587C Compressible enzyme powder
03/26/2003CA2423858A1 Novel proteins, genes encoding them and method of using the same
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003USRE38046 (delayed type sensitivity) DTH-Effector cells are printed with carbohydrate antigens; antitumor
03/25/2003US6538174 Animal model for transplantation
03/25/2003US6538123 Vaccine composition for preventing or treating hepatitis C
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538120 Genomic sequence of the human μ-opioid receptor gene and the variants, polymorphisms and mutations thereof
03/25/2003US6538118 Expression of lipoproteins
03/25/2003US6538116 For therapy of inflammatory or painful disorder
03/25/2003US6538114 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
1 ... 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 ... 3163